Download PDF
Am J Perinatol 2008; 25(3): 175-187
DOI: 10.1055/s-2008-1061497
© Thieme Medical Publishers

Multidimensional System Biology: Genetic Markers and Proteomic Biomarkers of Adverse Pregnancy Outcome in Preterm Birth

Catalin S. Buhimschi1 , Victor A. Rosenberg1 , Antonette T. Dulay1 , Stephen Thung1 , Anna K. Sfakianaki1 , Mert-Ozan Bahtiyar1 , Irina A. Buhimschi1
  • 1Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut
Further Information

Publication History

Publication Date:
27 February 2008 (online)

    Permissions and Reprints

ABSTRACT

Premature birth before 37 weeks of gestation is a significant public health problem. Each year, 4.5 million premature infants are born worldwide. Despite extensive research and a variety of interventions, the rate of preterm birth has steadily increased over the past 20 years and reached a high of 12.8% in 2006. The etiology of most preterm births remains elusive and is likely multifactorial, with many pathophysiological pathways involved, such as excessive stretching, oxidative stress, decidual hemorrhage, and infection. Genomics and proteomics have emerged to provide a better comprehension of the pathophysiological conditions leading to preterm birth, thereby providing a perspective for improving neonatal outcome.

KEYWORDS

Preterm birth - genomics - proteomics

REFERENCES

  • 1 Hamilton B E, Martin J A, Ventura S J. Births: final data for 2006.  National Vital Statistics Reports. 2007;  56 1-18
    PubMedGoogle Scholar
  • 2 Clements K M, Barfield W D, Ayadi M F et al.. Preterm birth-associated cost of early intervention services: an analysis by gestational age.  Pediatrics. 2007;  119 e866-e874
    CrossrefPubMedGoogle Scholar
  • 3 Flores-Santos R, Hernandez-Cabrera M A, Henandez-Herrera R J, Sepulveda-Canamar F. Screening for retinopathy of prematurity: results of a 7-year study of underweight newborns.  Arch Med Res. 2007;  38 440-443
    CrossrefPubMedGoogle Scholar
  • 4 Patra K, Wilson-Costello D, Taylor H G et al.. Grades I-II intraventricular hemorrhage in extremely low birth weight infants: effects on neurodevelopment.  J Pediatr. 2006;  149 169-173
    CrossrefPubMedGoogle Scholar
  • 5 Hintz S R, Kendrick D E, Vohr B R. National Institute of Child Health and Human Development Neonatal Research Network. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999.  Pediatrics. 2005;  115 1645-1651
    CrossrefPubMedGoogle Scholar
  • 6 Vincer M J, Allen A C, Joseph K S et al.. Increasing prevalence of cerebral palsy among very preterm infants: a population-based study.  Pediatrics. 2006;  118 e1621-e1626
    CrossrefPubMedGoogle Scholar
  • 7 Bhandari A, Bhandari V. Pathogenesis, pathology and pathophysiology of pulmonary sequelae of bronchopulmonary dysplasia in premature infants.  Front Biosci. 2003;  8 e370-e380
    CrossrefPubMedGoogle Scholar
  • 8 Grimes D A, Nanda K. Magnesium sulfate tocolysis: time to quit.  Obstet Gynecol. 2006;  108 986-989
    Google Scholar
  • 9 Thornton J G. Maintenance tocolysis.  BJOG. 2005;  112 118-121
    PubMedGoogle Scholar
  • 10 Hollier L M. Preventing preterm birth: what works, what doesn't.  Obstet Gynecol Surv. 2005;  60 124-131
    CrossrefPubMedGoogle Scholar
  • 11 Coomarasamy A, Knox E M, Gee H et al.. Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomised trials.  BJOG. 2003;  110 1045-1049
    PubMedGoogle Scholar
  • 12 King J, Flenady V, Cole S, Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour.  Cochrane Database Syst Rev. 2005;  2 CD001992
    PubMedGoogle Scholar
  • 13 Combs C A, McCune M, Clark R et al.. Aggressive tocolysis does not prolong pregnancy or reduce neonatal morbidity after preterm premature rupture of the membranes.  Am J Obstet Gynecol. 2004;  190 1723-1728
    CrossrefPubMedGoogle Scholar
  • 14 Lockwood C J. Testing for risk of preterm delivery.  Clin Lab Med. 2003;  23 345-360
    CrossrefPubMedGoogle Scholar
  • 15 Watson J D, Crick F H. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid.  Nature. 1953;  25 737-738
    PubMedGoogle Scholar
  • 16 Venter J C, Adams M D, Myers E W et al.. The sequence of the human genome.  Science. 2001;  291 1304-1351
    CrossrefPubMedGoogle Scholar
  • 17 US Department of Health and Human Services .“Innovation or Stagnation?-Challenge and Opportunity on the Critical Path to New Medical Products”. March 2004
    Google Scholar
  • 18 Lander E S, Schork N J. Genetic dissection of complex traits.  Science. 1994;  265 2037-2048
    CrossrefPubMedGoogle Scholar
  • 19 Zhu T, Salmeron J. High-definition genome profiling for genetic marker discovery.  Trends Plant Sci. 2007;  12 196-202
    CrossrefPubMedGoogle Scholar
  • 20 Hao K, Wang X, Niu T et al.. A candidate gene association study on preterm delivery: application of high-throughput genotyping technology and advanced statistical methods.  Hum Mol Genet. 2004;  13 683-691
    CrossrefPubMedGoogle Scholar
  • 21 Hillebrandt S, Matern S, Lammert F. Mouse models for genetic dissection of polygenic gastrointestinal diseases.  Eur J Clin Invest. 2003;  33 155-160
    CrossrefPubMedGoogle Scholar
  • 22 Nesin M. Genetic basis of preterm birth.  Front Biosci. 2007;  12 115-124
    CrossrefPubMedGoogle Scholar
  • 23 Lee S J, Steer P J, Filippi V. Seasonal patterns and preterm birth: a systematic review of the literature and an analysis in a London-based cohort.  BJOG. 2006;  113 1280-1288
    PubMedGoogle Scholar
  • 24 Gilbreath S, Kass P H. Adverse birth outcomes associated with open dumpsites in Alaska native villages.  Am J Epidemiol. 2006;  164 518-528
    CrossrefPubMedGoogle Scholar
  • 25 Macones G A, Parry S, Elkousy M et al.. A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth.  Am J Obstet Gynecol. 2004;  190 1504-1508
    CrossrefPubMedGoogle Scholar
  • 26 Crider K S, Whitehead N, Buus R M. Genetic variation associated with preterm birth: a HuGE review.  Genet Med. 2005;  7 593-604
    CrossrefPubMedGoogle Scholar
  • 27 Selling K E, Carstensen J, Finnstrom O et al.. Intergenerational effects of preterm birth and reduced intrauterine growth: a population-based study of Swedish mother-offspring pairs.  BJOG. 2006;  113 430-440
    CrossrefPubMedGoogle Scholar
  • 28 Melve K K, Skjaerven R, Gjessing H K et al.. Recurrence of gestational age in sibships: implications for perinatal mortality.  Am J Epidemiol. 1999;  150 756-762
    PubMedGoogle Scholar
  • 29 Winkvist A, Mogren I, Hogberg U. Familial patterns in birth characteristics: impact on individual and population risks.  Int J Epidemiol. 1998;  27 248-254
    CrossrefPubMedGoogle Scholar
  • 30 Porter T F, Fraser A M, Hunter C Y et al.. The risk of preterm birth across generations.  Obstet Gynecol. 1997;  90 63-67
    CrossrefPubMedGoogle Scholar
  • 31 Ward K, Argyle V, Meade M et al.. The heritability of preterm delivery.  Obstet Gynecol. 2005;  106 1235-1239
    CrossrefPubMedGoogle Scholar
  • 32 Treloar S A, Macones G A, Mitchell L E et al.. Genetic influences on premature parturition in an Australian twin sample.  Twin Res. 2000;  3 80-82
    CrossrefPubMedGoogle Scholar
  • 33 Aguan K, Carvajal J A, Thompson L P et al.. Application of a functional genomics approach to identify differentially expressed genes in human myometrium during pregnancy and labour.  Mol Hum Reprod. 2000;  6 1141-1145
    CrossrefPubMedGoogle Scholar
  • 34 Havelock J C, Keller P, Muleba N et al.. Human myometrial gene expression before and during parturition.  Biol Reprod. 2005;  72 707-719
    CrossrefPubMedGoogle Scholar
  • 35 Chan E C, Fraser S, Yin S. Human myometrial genes are differentially expressed in labor: a suppression subtractive hybridization study.  J Clin Endocrinol Metab. 2002;  87 2435-2441
    CrossrefPubMedGoogle Scholar
  • 36 Bukowski R, Hankins G D, Saade G R et al.. Labor-associated gene expression in the human uterine fundus, lower segment, and cervix.  PLoS Med. 2006;  3 e169
    CrossrefPubMedGoogle Scholar
  • 37 Mason C W, Buhimschi C S, Swaan P W et al.. Molecular genetic regulation of human myometrial activation and quiescence.  , Abstract #238 J Soc Gynecol Invest. 2006;  13 140A
    PubMedGoogle Scholar
  • 38 Mason C W, Buhimschi C S, Swaan P W et al.. Genomic 'prime time' players in preterm labor and term labor.  , Abstract #239 J Soc Gynecol Invest. 2006;  13 141A
    PubMedGoogle Scholar
  • 39 Buhimschi C S, Mason C W, Swaan P W et al.. Evidence that innate immunity is activated in myometrium from women in term and preterm labor.  , Abstract #221 J Soc Gynecol Invest. 2006;  13 135A
    PubMedGoogle Scholar
  • 40 Azuaje F, Al-Shahrour F, Dopazo J. Ontology-driven approaches to analyzing data in functional genomics.  Methods Mol Biol. 2006;  316 67-86
    PubMedGoogle Scholar
  • 41 Scharpf R B, Ting J C, Pevsner J, Ruczinski I. SNP chip: R classes and methods for SNP array data.  Bioinformatics. 2007;  23 627-628
    CrossrefPubMedGoogle Scholar
  • 42 Meirhaeghe A, Boreham C A, Murray L J. A possible role for the PPARG Pro12Ala polymorphism in preterm birth.  Diabetes. 2007;  56 494-498
    CrossrefPubMedGoogle Scholar
  • 43 Murtha A P, Nieves A, Hauser E R et al.. Association of maternal IL-1 receptor antagonist intron 2 gene polymorphism and preterm birth.  Am J Obstet Gynecol. 2006;  195 1249-1253
    CrossrefPubMedGoogle Scholar
  • 44 Menon R, Merialdi M, Betran A P. Analysis of association between maternal tumor necrosis factor-alpha promoter polymorphism (-308), tumor necrosis factor concentration, and preterm birth.  Am J Obstet Gynecol. 2006;  195 1240-1248
    CrossrefPubMedGoogle Scholar
  • 45 Wang H, Parry S, Macones G et al.. A functional SNP in the promoter of the SERPINH1 gene increases risk of preterm premature rupture of membranes in African Americans.  Proc Natl Acad Sci U S A. 2006;  103 13463-13467
    CrossrefPubMedGoogle Scholar
  • 46 Bodamer O A, Mitterer G, Maurer W et al.. Evidence for an association between mannose binding lectin 2 (MBL2) gene polymorphisms and pre-term birth.  Genet Med. 2006;  8 518-524
    CrossrefPubMedGoogle Scholar
  • 47 Menon R, Velez D R, Simhan H et al.. Multilocus interactions at maternal tumor necrosis factor-alpha, tumor necrosis factor receptors, interleukin-6 and interleukin-6 receptor genes predict spontaneous preterm labor in European-American women.  Am J Obstet Gynecol. 2006;  194 1616-1624
    CrossrefPubMedGoogle Scholar
  • 48 Lawlor D A, Gaunt T R, Hinks L J et al.. The association of the PON1 Q192R polymorphism with complications and outcomes of pregnancy: findings from the British Women's Heart and Health cohort study.  Paediatr Perinat Epidemiol. 2006;  20 244-250
    CrossrefPubMedGoogle Scholar
  • 49 Chen D, Hu Y, Chen C et al.. Polymorphisms of the paraoxonase gene and risk of preterm delivery.  Epidemiology. 2004;  15 466-470
    CrossrefPubMedGoogle Scholar
  • 50 Kalish R B, Vardhana S, Normand N J et al.. Association of a maternal CD14 -159 gene polymorphism with preterm premature rupture of membranes and spontaneous preterm birth in multi-fetal pregnancies.  J Reprod Immunol. 2006;  70 109-117
    PubMedGoogle Scholar
  • 51 Hartel C, von Otte S, Koch J et al.. Polymorphisms of haemostasis genes as risk factors for preterm delivery.  Thromb Haemost. 2005;  94 88-92
    PubMedGoogle Scholar
  • 52 Engel S A, Erichsen H C, Savitz D A et al.. Risk of spontaneous preterm birth is associated with common proinflammatory cytokine polymorphisms.  Epidemiology. 2005;  16 469-477
    CrossrefPubMedGoogle Scholar
  • 53 Johnson W G, Scholl T O, Spychala J R et al.. Common dihydrofolate reductase 19-base pair deletion allele: a novel risk factor for preterm delivery.  Am J Clin Nutr. 2005;  81 664-668
    PubMedGoogle Scholar
  • 54 Engel S A, Erichsen H C, Savitz D A et al.. Risk of spontaneous preterm birth is associated with common proinflammatory cytokine polymorphisms.  Epidemiology. 2005;  16 469-477
    CrossrefPubMedGoogle Scholar
  • 55 Kalish R B, Nguyen D P, Vardhana S et al.. A single nucleotide A> G polymorphism at position -670 in the Fas gene promoter: relationship to preterm premature rupture of fetal membranes in multifetal pregnancies.  Am J Obstet Gynecol. 2005;  192 208-212
    CrossrefPubMedGoogle Scholar
  • 56 Annells M F, Hart P H, Mullighan C G et al.. Interleukins-1, -4, -6, -10, tumor necrosis factor, transforming growth factor-beta, FAS, and mannose-binding protein C gene polymorphisms in Australian women: risk of preterm birth.  Am J Obstet Gynecol. 2004;  191 2056-2067
    CrossrefPubMedGoogle Scholar
  • 57 Hartel C H, Finas D, Ahrens P et al.. Genetic factors in Neonatology Study Group. Polymorphisms of genes involved in innate immunity: association with preterm delivery.  Mol Hum Reprod. 2004;  10 911-915
    CrossrefPubMedGoogle Scholar
  • 58 Resch B, Gallistl S, Kutschera J et al.. Thrombophilic polymorphisms-factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations-and preterm birth.  Wien Klin Wochenschr. 2004;  116 622-626
    CrossrefPubMedGoogle Scholar
  • 59 Amory J H, Adams K M, Lin M T et al.. Adverse outcomes after preterm labor are associated with tumor necrosis factor-alpha polymorphism -863, but not -308, in mother-infant pairs.  Am J Obstet Gynecol. 2004;  191 1362-1367
    CrossrefPubMedGoogle Scholar
  • 60 Genc M R, Onderdonk A B, Vardhana S et al.. MAP Study Group. Polymorphism in intron 2 of the interleukin-1 receptor antagonist gene, local midtrimester cytokine response to vaginal flora, and subsequent preterm birth.  Am J Obstet Gynecol. 2004;  191 1324-1330
    CrossrefPubMedGoogle Scholar
  • 61 Nguyen D P, Genc M, Vardhana S et al.. Ethnic differences of polymorphisms in cytokine and innate immune system genes in pregnant women.  Obstet Gynecol. 2004;  104 293-300
    PubMedGoogle Scholar
  • 62 Valdez L L, Quintero A, Garcia E et al.. Thrombophilic polymorphisms in preterm delivery.  Blood Cells Mol Dis. 2004;  33 51-56
    CrossrefPubMedGoogle Scholar
  • 63 Kalish R B, Vardhana S, Gupta M et al.. Interleukin-4 and -10 gene polymorphisms and spontaneous preterm birth in multifetal gestations.  Am J Obstet Gynecol. 2004;  190 702-706
    CrossrefPubMedGoogle Scholar
  • 64 Moore S, Ide M, Randhawa M et al.. An investigation into the association among preterm birth, cytokine gene polymorphisms and periodontal disease.  BJOG. 2004;  111 125-132
    CrossrefPubMedGoogle Scholar
  • 65 Wang H, Parry S, Macones G et al.. Functionally significant SNP MMP8 promoter haplotypes and preterm premature rupture of membranes (PPROM).  Hum Mol Genet. 2004;  13 2659-2669
    CrossrefPubMedGoogle Scholar
  • 66 Ferrand P E, Parry S, Sammel M et al.. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans.  Mol Hum Reprod. 2002;  8 494-501
    CrossrefPubMedGoogle Scholar
  • 67 Witkin S S, Vardhana S, Yih M et al.. Polymorphism in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences midtrimester amniotic fluid concentrations of interleukin-1beta and interleukin-1 receptor antagonist and pregnancy outcome.  Am J Obstet Gynecol. 2003;  189 1413-1417
    CrossrefPubMedGoogle Scholar
  • 68 Simhan H N, Krohn M A, Roberts J M et al.. Interleukin-6 promoter -174 polymorphism and spontaneous preterm birth.  Am J Obstet Gynecol. 2003;  189 915-918
    CrossrefPubMedGoogle Scholar
  • 69 Lorenz E, Hallman M, Marttila R et al.. Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population.  Pediatr Res. 2002;  52 373-376
    CrossrefPubMedGoogle Scholar
  • 70 Aidoo M, McElroy P D, Kolczak M S et al.. Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX.  Genet Epidemiol. 2001;  21 201-211
    CrossrefPubMedGoogle Scholar
  • 71 Roberts A K, Monzon-Bordonaba F, Van Deerlin P G et al.. Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm premature rupture of the fetal membranes.  Am J Obstet Gynecol. 1999;  180 1297-1302
    CrossrefPubMedGoogle Scholar
  • 72 Orsi N M, Gopichandran N, Simpson N A. Genetics of preterm labour.  Best Pract Res Clin Obstet Gynaecol. 2007;  21(5) 757-772
    CrossrefPubMedGoogle Scholar
  • 73 Densem C G, Hutchinson I V, Yonan N et al.. Donor and recipient-transforming growth factor-beta 1 polymorphism and cardiac transplant-related coronary artery disease.  Transpl Immunol. 2004;  13 211-217
    PubMedGoogle Scholar
  • 74 Sinsheimer J S, Palmer C G, Woodward J A. Detecting genotype combinations that increase risk for disease: maternal-fetal genotype incompatibility test.  Genet Epidemiol. 2003;  24 1-13
    CrossrefPubMedGoogle Scholar
  • 75 The International HapMap Consortium . The International HapMap Project.  Nature. 2003;  426 789-796
    CrossrefPubMedGoogle Scholar
  • 76 Lieber C D. Introduction to proteomics. In: Lieber CD Tools for the New Biology. Totowa, NJ; Humana Press 2002: 3-14
    Google Scholar
  • 77 Tammen H, Peck A, Budde P et al.. Peptidomics analysis of human blood specimens for biomarker discovery.  Expert Rev Mol Diagn. 2007;  7 605-613
    CrossrefPubMedGoogle Scholar
  • 78 Buhimschi C S, Weiner C P, Buhimschi I A. Clinical proteomics: a novel diagnostic tool for the new biology of preterm labor: PartI Proteomics tools.  Obstet Gynecol Surv. 2006;  61 481-486
    CrossrefPubMedGoogle Scholar
  • 79 Bahtiyar M O, Copel J A, Mahoney M J et al.. Proteomics: a novel methodology to complement prenatal diagnosis of chromosomal abnormalities and inherited human diseases.  Am J Perinatol. 2007;  24 167-181
    Article in Thieme ConnectPubMedGoogle Scholar
  • 80 Lockwood C J. Pregnancy-associated changes in the hemostatic system.  Clin Obstet Gynecol. 2006;  49 836-843
    PubMedGoogle Scholar
  • 81 Salafia C M, Lopez-Zeno J A, Sherer D M et al.. Histologic evidence of old intrauterine bleeding is more frequent in prematurity.  Am J Obstet Gynecol. 1995;  173 1065-1070
    CrossrefPubMedGoogle Scholar
  • 82 Lockwood C J, Krikun G, Rahman M et al.. The role of decidualization in regulating endometrial hemostasis during the menstrual cycle, gestation, and in pathological states.  Semin Thromb Hemost. 2007;  33 111-117
    Article in Thieme ConnectPubMedGoogle Scholar
  • 83 Weiner C P, Lee K Y, Buhimschi C S et al.. Proteomic biomarkers that predict the clinical success of rescue cerclage.  Am J Obstet Gynecol. 2005;  192 710-718
    CrossrefPubMedGoogle Scholar
  • 84 Buhimschi I A, Christner R, Buhimschi C S. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation.  BJOG. 2005;  112 173-181
    PubMedGoogle Scholar
  • 85 ACOG Committee on Practice Bulletins-Obstetrics . ACOG Practice Bulletin No. 80: Premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists.  Obstet Gynecol. 2007;  109 1007-1019
    PubMedGoogle Scholar
  • 86 Locatelli A, Ghidini A, Paterlini G et al.. Gestational age at preterm premature rupture of membranes: a risk factor for neonatal white matter damage.  Am J Obstet Gynecol. 2005;  193 947-951
    CrossrefPubMedGoogle Scholar
  • 87 Buhimschi I A, Kramer W B, Buhimschi C S. Reduction-oxidation (redox) state regulation of matrix metalloproteinase activity in human fetal membranes.  Am J Obstet Gynecol. 2000;  182 458-464
    CrossrefPubMedGoogle Scholar
  • 88 Menon R, Fortunato S J. The role of matrix degrading enzymes and apoptosis in rupture of membranes.  J Soc Gynecol Investig. 2004;  11 427-437
    CrossrefPubMedGoogle Scholar
  • 89 Vuadens F, Benay C, Crettaz D et al.. Identification of biologic markers of the premature rupture of fetal membranes: proteomic approach.  Proteomics. 2003;  3 1521-1525
    CrossrefPubMedGoogle Scholar
  • 90 Thadikkaran L, Crettaz D, Siegenthaler M A et al.. The role of proteomics in the assessment of premature rupture of fetal membranes.  Clin Chim Acta. 2005;  360 27-36
    CrossrefPubMedGoogle Scholar
  • 91 Michel P E, Crettaz D, Morier P et al.. Proteome analysis of human plasma and amniotic fluid by Off-Gel isoelectric focusing followed by nano-LC-MS/MS.  Electrophoresis. 2006;  27 1169-1181
    CrossrefPubMedGoogle Scholar
  • 92 Davis N M, Ford G W, Anderson P J et al.. Developmental coordination disorder at 8 years of age in a regional cohort of extremely-low-birthweight or very preterm infants.  Dev Med Child Neurol. 2007;  49 325-330
    PubMedGoogle Scholar
  • 93 Maalouf E F, Duggan P J, Rutherford M A et al.. Magnetic resonance imaging of the brain in a cohort of extremely preterm infants.  J Pediatr. 1999;  135 351-357
    PubMedGoogle Scholar
  • 94 Green N S, Damus K, Simpson J L et al.. March of Dimes Scientific Advisory Committee on Prematurity. Research agenda for preterm birth: recommendations from the March of Dimes.  Am J Obstet Gynecol. 2005;  193 626-635
    CrossrefPubMedGoogle Scholar
  • 95 Gravett M G, Novy M J, Rosenfeld R G et al.. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers.  JAMA. 2004;  292 462-469
    CrossrefPubMedGoogle Scholar
  • 96 Vuadens F, Benay C, Crettaz D et al.. Identification of biologic markers of the premature rupture of fetal membranes: proteomic approach.  Proteomics. 2003;  3 1521-1525
    CrossrefPubMedGoogle Scholar
  • 97 Michel P E, Crettaz D, Morier P et al.. Proteome analysis of human plasma and amniotic fluid by Off-Geltrade mark isoelectric focusing followed by nano-LC-MS/MS.  Electrophoresis. 2006;  27 1169-1181
    CrossrefPubMedGoogle Scholar
  • 98 Ruetschi U, Rosen A, Karlsson G et al.. Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation.  J Proteome Res. 2005;  4 2236-2242
    CrossrefPubMedGoogle Scholar
  • 99 Buhimschi C S, Pettker C M, Magloire L K et al.. Proteomic technology and delayed interval delivery in multiple pregnancies.  Int J Gynaecol Obstet. 2005;  90 48-50
    CrossrefPubMedGoogle Scholar
  • 100 Buhimschi C S, Weiner C P, Buhimschi I A. Proteomics: Part II The emerging role of proteomics over genomics in spontaneous preterm labor/birth.  Obstet Gynecol Surv. 2006;  61 543-553
    CrossrefPubMedGoogle Scholar
  • 101 Sampson J E, Theve R P, Blatman R N et al.. Fetal origin of amniotic fluid polymorphonuclear leukocytes.  Am J Obstet Gynecol. 1997;  176 77-81
    CrossrefPubMedGoogle Scholar
  • 102 Buhimschi C S, Bhandari V, Hamar B D et al.. Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis.  PLoS Med. 2007;  4 e18
    CrossrefPubMedGoogle Scholar
  • 103 Nien J K, Yoon B H, Espinoza J et al.. A rapid MMP-8 bedside test for the detection of intra-amniotic inflammation identifies patients at risk for imminent preterm delivery.  Am J Obstet Gynecol. 2006;  195 1025-1030
    CrossrefPubMedGoogle Scholar
  • 104 Bianchi D W. At-home fetal DNA gender testing: caveat emptor.  Obstet Gynecol. 2006;  107 216-218
    PubMedGoogle Scholar
  • 105 Di Quinzio M K, Oliva K, Holdsworth S J et al.. Proteomic analysis and characterisation of human cervico-vaginal fluid proteins.  Aust N Z J Obstet Gynaecol. 2007;  47 9-15
    CrossrefPubMedGoogle Scholar
  • 106 Pereira L, Reddy A P, Jacob T et al.. Identification of novel protein biomarkers of preterm birth in human cervical-vaginal fluid.  J Proteome Res. 2007;  6 1269-1276
    CrossrefPubMedGoogle Scholar
  • 107 Buhimschi I A, Buhimschi C S, Weiner C P et al.. Proteomic but not enzyme-linked immunosorbent assay technology detects amniotic fluid monomeric calgranulins from their complexed calprotectin form.  Clin Diagn Lab Immunol. 2005;  12 837-844
    CrossrefPubMedGoogle Scholar
  • 108 Buhimschi I A, Buhimschi C S, Hamar B et al.. Proteomic analysis of the vaginal amniotic fluid in patients with preterm premature rupture of the membranes (PPROM).  , Abstract #287 Am J Obstet Gynecol. 2004;  191 S87
    PubMedGoogle Scholar
  • 109 Buhimschi I A, Buhimschi C S, Weiner C P. Protective effect of N-acetylcysteine against fetal death and preterm labor induced by maternal inflammation.  Am J Obstet Gynecol. 2003;  188 203-208
    CrossrefPubMedGoogle Scholar
  • 110 Beloosesky R, Gayle D A, Amidi F et al.. N-acetyl-cysteine suppresses amniotic fluid and placenta inflammatory cytokine responses to lipopolysaccharide in rats.  Am J Obstet Gynecol. 2006;  194 268-273
    CrossrefPubMedGoogle Scholar

Catalin S BuhimschiM.D. 

Director of Perinatal Research, Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine

333 Cedar Street, LLCI 804, New Haven, CT 06520

      >